• Barel S, Yagen B, Schurig V, Soback S, Pisani F, Perucca E, Bialer M. (1997) Strereoselective pharmacokinetic analysis of valnoctamide in healthy subjects and epileptic patients. Clin Pharmacol Ther 61:442449.
  • Bautista RE, Godwin S, Caro D. (2007) Incorporating abbreviated EEGs in initial workup of patients who present to emergency room with mental status changes of unknown etiology. J Clin Neurophysiol 24:1621.
  • Bersudsky Y, Applebaum Y, Sharony A, Mishory A, Poderbeasky A, Agam G, Belmaker RH. (2010) Valnoctamide as valproate substitute with low teratogenic potential in mania: double blind controlled clinical trial. Bipolar Disorder 12:376382.
  • Bialer M. (2012) Chemical properties of antiepileptic drugs (AEDs). Adv Drug Deliv Rev 64:887895.
  • Bialer M, White HS. (2010) Key factors in the discovery and development of new antiepileptic drugs (AEDs). Nature Rev Drug Discov 9:6883.
  • Bialer M, Yagen B. (2007) Valproic acid – Second generation. Neurotherapeutics 4:130137.
  • Bialer M, Johannessen SI, Levy RH, Perucca E, Tomson T, White HS. (2010) Progress report on new antiepileptic drugs: a summary of the Tenth Eilat Conference (EILAT X). Epilepsy Res 92:89124.
  • Bialer M, Johannessen SI, Levy RH, Perucca E, Tomson T, White HS. (2013) Progress report on new antiepileptic drugs: a summary of the Eleventh Eilat Conference (EILAT XI). Epilepsy Res 103:230.
  • Isoherranen N, White HS, Klein BD, Roeder M, Woodhead JH, Schurig V, Yagen B, Bialer M. (2003) Pharmacokinetic-pharmacodynamic relationships of (2S,3S)-valnoctamide and its stereoisomer (2R,3S)-valnoctamide in rodent models of epilepsy. Pharm Res 20:12931301.
  • Kaufmann D, Bialer M, Yagen B, Shimshoni A, Devor M, Yagen B. (2009) Synthesis and evaluation of antiallodynic and anticonvulsant activity of novel amide and urea derivatives of valproic aid analogues. J Med Chem 52:72367248.
  • Kaufmann D, Yagen B, Minert A, Wlodarczyk B, Finnell R, Schrig V, Devor M, Bialer M. (2010) Evaluation of the antiallodynic, teratogenic and pharmacokinetic profile of stereoisomers of valnoctamide, an amide derivative of a chiral isomer of valproic acid. Neuropharmacology 52:12281236.
  • Lehmkuhle MJ, Thomson KE, Scheelinck P, Pouliot W, Greger B, Dudek FE. (2009) A simple quantitative method for analyzing electrographic status epilepticus in rats. J Neurophysiol 1010:16601670.
  • McDonough JH, Zoeffel LD, McMonagle J, Copeland TL, Smith CD, Shih TM. (2000) Anticonvulsant treatment of nerve agent seizures: anticholinergics versus diazepam in soman-intoxicated guinea pigs. Epilepsy Res 38:114.
  • Pouliot W, Bialer M, Hen N, Shekh-Ahmad T, Kaufmann D, Yagen B, Ricks K, Roach B, Nelson C, Dudek FE. (2013) A comparative electrographic analysis of the effect of sec-butyl-propylacetamide on pharmacoresistant status epilepticus. Neuroscience 231:145156.
  • White HS, Woodhead JH, Wilcox KS, Stables JP, Kupferberg HJ, Wolf HH. (2002) Discovery and preclinical development of antiepileptic drugs. In Levy RH, Mattson RH, Meldrum BS, Perucca E (Eds) Antiepileptic drugs, 5th ed. Lippincott Williams & Wilkins Publishers, New York, pp 3648.
  • White HS, Alex AB, Pollock A, Hen N., Shekh-Ahmed T, Wilcox KS, McDonough JH, Stables J, Kaufmann D, Yagen B, Bialer M. (2012) A new derivative of valproic acid amide possesses a broad-spectrum antiseizure profile and unique activity against status epilepticus and organophosphate neuronal damage. Epilepsia 53:134146.